Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Santa Rosa
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Santa Rosa, CA

Studies commonly pay $75 to $4,500 per completed study

148 clinical trials are currently recruiting participants within 30 miles of Santa Rosa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

148studies recruiting
8+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Santa Rosa right now

Top 25 of 148 recruiting studies, sorted by proximity — each links to its official registry page

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Metastatic Breast Cancer Phase 3 Interventional 600 participants sought
Providence Medical Foundation - Santa Rosa, CA — Santa Rosa, California (0.6 mi) · Sponsor: LeonaBio
See eligibility & contact on ClinicalTrials.gov (NCT05696626)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Santa Rosa, California (0.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

SELUTION4BTK Trial

Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities N/A Interventional 376 participants sought
St. Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: M.A. Med Alliance S.A.
See eligibility & contact on ClinicalTrials.gov (NCT05055297)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05327686)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Colorectal Neoplasms Phase 3 Interventional 1,000 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06662786)

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04628767)

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC) Phase 1 Interventional 260 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: IDEAYA Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07277413)

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Advanced Cancer, Metastatic Cancer Phase 1, Phase 2 Interventional 542 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Artios Pharma Ltd
See eligibility & contact on ClinicalTrials.gov (NCT04657068)

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Airway Drive Care Center — Santa Rosa, California (0.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222800)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Persistent Corneal Epithelial Defect Phase 2 Interventional 84 participants sought
Glaukos Investigative Site — Petaluma, California (15.2 mi) · Sponsor: Glaukos Corporation
See eligibility & contact on ClinicalTrials.gov (NCT05966493)

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Transthyretin Amyloid Cardiomyopathy (ATTR CM) Phase 3 Interventional 1,280 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07207811)

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Peripheral Vascular Diseases N/A Observational 5,000 participants sought
Adventist Health St Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT04674969)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT06592924)

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Locally Advanced Solid Tumors, Metastatic Solid Tumors Phase 1, Phase 2 Interventional 500 participants sought
St Joseph Heritage Healthcare — Santa Rosa, California (0.6 mi) · Sponsor: Turning Point Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT03093116)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT03150693)

A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OH) Phase 3 Interventional 600 participants sought
North Bay Eye Associates — Petaluma, California (15.2 mi) · Sponsor: YS Life Science Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07661329)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)
Actively enrolling

Studies you may be able to join near Santa Rosa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Santa Rosa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Providence Medical Group Santa Rosa - Clinical Trials

3555 Round Barn Cir, Santa Rosa, CA 95403
(707) 521-3830

Siyan Clinical Corporation

★ 4.8 (564 reviews)
480 Tesconi Cir Ste B, Santa Rosa, CA 95401
(707) 206-7268

TrueNorth Health Center

★ 4.4
1551 Pacific Ave, Santa Rosa, CA 95404
(707) 586-5555

Santa Rosa Behavioral Healthcare Hospital

★ 2.2 (244 reviews)
1287 Fulton Rd, Santa Rosa, CA 95401
(707) 800-7700
"Everyone that works there (except for the kitchen staff) knows how to treat people and do their best even when others (patience) are not trying to he…"
— Lamar Manuel, 5★

Sunwise Clinical Research

★ 4.7
1371 Oakland Blvd #301, Walnut Creek, CA 94596
(925) 298-5147
"They are a great group of people"
— Tree Sap, 5★

Evolve Restorative Center

★ 4.1 (53 reviews)
220 Concourse Blvd, Santa Rosa, CA 95403
(844) 527-7369
"First time I've been to this practice....and it will be my last. Looks like a nice facility but staff are robotic and appear to care less about thei…"
— Mike Antill, 1★

Oakland Clinical

3300 Webster St #1106, Oakland, CA 94609
(510) 817-2000

CPMC Research Institute

★ 5.0
2330 Clay St, San Francisco, CA 94115
(415) 561-1785

Clinical trials in Santa Rosa: what's recruiting

The Santa Rosa area currently has 148 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Santa Rosa, the most active research areas are:

  • Cancer & Oncology17 studies
  • Liver & Kidney4 studies
  • Heart & Vascular3 studies

Every listing shows the study phase, the recruiting site and its distance from Santa Rosa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Santa Rosa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Santa Rosa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Santa Rosa pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Santa Rosa safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Santa Rosa, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Santa Rosa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Santa Rosa typically complete one or two studies per year.

Paid clinical trials near Santa Rosa

Other metros within reach

Vallejo, CA1,512 Fairfield, CA348 San Francisco, CA2,239 Oakland, CA2,257 Concord, CA1,523 Antioch, CA457 Hayward, CA2,267 Fremont, CA2,257

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Santa Rosa Bladder Issues Due To Spinal Cord Injury in Santa Rosa All conditions

More of CA

Long Beach3,380 Fullerton3,270 Torrance3,259 Anaheim3,214 Garden Grove3,204 Pomona3,172 Glendale2,974 Los Angeles2,951 Huntington Beach2,879 Santa Clarita2,378 Hayward2,267 Oakland2,257

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts